- ICH GCP
- 미국 임상 시험 레지스트리
- Search trials
임상 시험 검색 : kidney transplant recipients
총 27954 건
-
LeMaitre Vascular종료됨
-
NovaCardia, Inc.Merck Sharp & Dohme LLC완전한
-
Meander Medical CenterDutch Kidney Foundation완전한
-
MaineHealthMaine Medical Center Mentored Research Committee완전한
-
University Hospital, Caen종료됨
-
VentracorInternational Center for Health Outcomes and Innovation Research완전한
-
University Hospital MuensterMerck Sharp & Dohme LLC; Gilead Sciences완전한
-
Rigshospitalet, DenmarkDanish Heart Foundation; Copenhagen Hospital Corporation종료됨
-
Nabi Biopharmaceuticals완전한동맥 경화증 | 부갑상선기능항진증, 속발성 | 석회화미국
-
Aptose Biosciences Inc.University of Chicago; Wake Forest University완전한
-
National Institute of Arthritis and Musculoskeletal...University of Pittsburgh; Genzyme, a Sanofi Company; Amgen종료됨
-
Wyeth is now a wholly owned subsidiary of Pfizer종료됨
-
Cell Genesys완전한
-
Hadassah Medical Organization알려지지 않은Female Patients Aged 5-35 Prior to Systemic Chemotherapy | With Significant Risk of Ovarian Toxicity이스라엘
-
Fred Hutchinson Cancer CenterNational Institutes of Health (NIH); Burroughs Wellcome완전한
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)완전한
-
Eli Lilly and Company완전한부패 | 혈액학적 신생물 | 전염병 | 조혈모세포이식미국
-
Seoul National University Hospital알려지지 않은
-
Charite University, Berlin, Germany알려지지 않은
-
Shanghai Municipal Health Bureau알려지지 않은단백뇨 | 안지오텐신 II 유형 1 수용체 차단제 | 만성 신부전 | 안지오텐신 전환 효소 억제제중국
-
Institute of Child Health알려지지 않은
-
National Taiwan University Hospital알려지지 않은
-
Ann & Robert H Lurie Children's Hospital of ChicagoAmerican College of Gastroenterology완전한
-
University of NebraskaGenzyme, a Sanofi Company알려지지 않은
-
University of WuerzburgDeutsche Stiftung für Herzforschung알려지지 않은
-
Shanghai Jiao Tong University School of Medicine완전한당뇨병성 신증 | 제2형 당뇨병 | 뚱뚱한 | 포도당 대사 | 안지오텐신 II 유형 1 수용체 차단제